The Oxford Communique

The Goals of The Oxford Communiqué include…

promotion

The Oxford Club’s flagship newsletter, headed by Chief Investment Strategist Alexander Green is one of the best-regarded publications in the industry. Each month, subscribers receive Alex’s thoughts on the market and latest investment recommendation, as well as wealth building insights from ETF Strategist Nicholas Vardy. Not only is The Oxford Communiqué dedicated to providing market-beating returns, but it also explores the true meaning of wealth through means beyond financial assets alone.

The goals of the Oxford Communiqué include…

  • Maximizing your income…
  • Minimizing your taxes…
  • Doubling the broad market returns…
  • Minimizing market risks…

And perhaps most importantly…

Allowing you to live a financially free life without money worries and concerns.

Check Out Our Latest Opportunity

What to Expect

promotion

Every month, Members receive Alex’s and Nicholas’ thoughts on the market and their latest investment ideas. The newsletter is posted to the Club’s website in the third week of each month, with a printed version arriving just a week or so later.

We also email the weekly Oxford Communiqué Portfolio Update where Alex provides information about what’s going on with key positions in the portfolios.

 

Impressive Facts

Track Record for 2018

111

Number of Winning Positions

7

Number of Winning Stocks With Triple-Digit Returns

Learn More

The independent Hulbert Financial Digest has ranked his Oxford Communiqué as one of the 10 top-performing investment letters in the nation for the last 15 years.

Furthermore, since their inceptions…

  • The Oxford Trading Portfolio has outperformed the S&P 500 by 280%.

  • The Ten-Baggers of Tomorrow Portfolio has multiple double-digit winners.
  • The Oxford All-Star Portfolio has grown by more than 120%.
  • The conservative Gone Finish’ Portfolio has nearly quadrupled in value.

As a specific example, Alex wrote a story a few years back about a cancer-fighting company called Varian Medical Systems.

When he first started researching it, it traded for just $23.

Presently, Varian has topped $120 per share. 1,000 shares would now be worth $1.38 million!